Relationship of Noninvasive Assessment of Central BP With 10 Years Atherosclerotic CVD in Subclinical Hypothyroidism
1 other identifier
observational
100
0 countries
N/A
Brief Summary
verify Relationship of noninvasive assessment of central arterial blood pressure with 10 years Atherosclerotic Cardiovascular disease (ASCVD) in Subclinical hypothyroidism
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2024
CompletedFirst Posted
Study publicly available on registry
September 23, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
September 24, 2024
September 1, 2024
1.9 years
September 19, 2024
September 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Assess the extent to which subclinical hypothyroidism is associated with atherosclerotic cardiovascular disease
the extent to which subclinical hypothyroidism is associated with atherosclerotic cardiovascular disease
2025
Study Arms (2)
patients with subclinical hypothyroidism admitted to internal medicine department.
patients with subclinical hypothyroidism admitted to internal medicine department.
healthy match individual .
healthy match individual
Eligibility Criteria
Full Personal history will include: Demographic data age, sex, material status, smoking history, residence (rural, urban) ,presence of previous medical disease (DM ,HTN, cardiac ,renal disease). Full medical history will include Duration of the disease, history of treatment intake ,history of autoimmune disease
You may qualify if:
- Age 18-70
- Both sex
You may not qualify if:
- Patients had thyroidectomy operation
- Patients with a history of encompassing acute coronary syndrome (ACS).
- Myocardial infarction (MI).
- Coronary heart disease (CHD).
- Cerebrovascular diseases or other arterial revascularization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Mohamed Faisal, Doctor
Dr/ Mohamed Faisal El Adway
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 19, 2024
First Posted
September 23, 2024
Study Start
October 1, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
September 24, 2024
Record last verified: 2024-09